A practical view on the implementation of SRD II
It is almost one year since the adoption of the Belgian law implementing the Shareholder Rights Directive II (SRD II).
With SRD II came new rights and new opportunities for listed companies, but how can issuers benefit from this?
View the webinar by clicking the 'Start Now' button.
Investor Relations Officer atMithra Pharmaceuticals
Partner at Freshfields
Director Product Management at Euroclear Belgium
Head of Advisory and IR Solutions at Euronext Corporate Services
Benoît van den Hove
Job title at Company
The objective of the SRD Il is to encourage long-term shareholder engagement, ensuring enhanced transparency and promoting discussions between issuers and investors.
Among the provisions, this new directive allows issuers to identify their shareholder base.
How will SRD Il impact interactions between issuers and shareholders?
How will SRD Il interface with other provisions of Belgian law?
Performing a shareholder identification - the advantage of knowing your investors
About Shareholder AnalysisShareholder Analysis provides a comprehensive, dynamic and clear vision of your capital structure through several features:
Enriched and detailed share register from local CSD